Pilot Study of Real-time Automated Tracking System for Patients With Epilepsy

University of California, San Francisco1 site in 1 countryJuly 2010

ConditionsEpilepsy

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Epilepsy
Sponsor: University of California, San Francisco
Locations: 1
Primary Endpoint: Quality of life
Status: Withdrawn
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The investigators propose a novel method for tracking the seizure frequency, side effect burden, and medication compliance for patients with epilepsy. The investigators intend to utilize a table-top device currently for tracking other chronic disease to collect remote data from epilepsy patients. The hypothesis is that the use of this device will lead to better longterm treatment outcomes than the standard outpatient mechanism of following patients longitudinally.

Registry

clinicaltrials.gov

Start Date

July 2010

End Date

July 2013

Last Updated

9 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University of California, San Francisco

Responsible Party

Principal Investigator

John Hixson

Associate Professor of Neurology

University of California, San Francisco

Eligibility Criteria

Inclusion Criteria

•Eligible participants must have a definitive diagnosis of epilepsy for at least 6 months, based on the clinical judgement of the investigators. Epilepsy is defined by two or more unprovoked seizures. Clinical history, electroencephalography, and imaging data are all instrumental in rendering a formal decision. The seizure type, frequency, or severity are not criteria for exclusion, although this information will be recorded.
•Patient can range in age from birth to 65 years old; in cases of child participants, the parents are responsible for data reporting.
•Patients must have a seizure frequency of at least two seizures in a 6 month period of time.
•Patients must be on at least one anti-epileptic medication.
•Patients and/or legal guardian must be able to report seizure frequency with either a paper or electronic diary.
•Patients and/or legal guardians must be able to read and understand either English or Spanish.
•Patients and/or legal guardians must be able to complete questionnaires and provide informed consent to this study.

Exclusion Criteria

•Exclusion criteria include: a diagnosis of psychogenic nonepileptic seizures; severe depression, anxiety, or psychosis
•Recent problem with substance abuse.